Limosilactobacillus reuteri strain with high riboflavin production and uses thereof
AssigneeUniversiteit Antwerpen
InventorsSarah Lebeer, Sarah Ahannach, Irina Spacova, Stijn Wittouck
Life of this patent
Estimating the term…
Abstract
The present invention to the identification of a novel isolated bacterial strain, the Limosilactobacillus reuteri strain which is characterized by a naturally occurring overproduction of riboflavin (vitamin B2) compared to other known strains of lactobacilli. Said strain of the Limosilactobacillus species is deposited under accession number LMG P-32020. In a further aspect, also the uses of said L. reuteri strain are disclosed herein. In particular, the use of said strain in food and feed industry, human and veterinary health, large-scale vitamin production, cosmetics and consumer care products is disclosed.
Claims16
A method of supplementing a subject experiencing riboflavin deficiency, the method comprising administering a probiotic or synbiotic composition to the subject, the probiotic or synbiotic composition comprising an isolated bacterial strain of Lactobacillus reuteri, the strain deposited under accession number LMG P-32020.
Dependencies are inferred from the claim text.